Moreover, we identified evidence to support previously implicated targets, such as CLCN3 (schizophrenia, P = 5.99 × 10−7), which have been reported to play a role in the control of glutamatergic transmission (35). This evidence concerns the gene CLCN3 and schizophrenia.